In a guest post on the Center for Global Health Policy's "Science Speaks" blog, Margaret McGlynn, president and CEO of the International AIDS Vaccine Initiative (IAVI), and William Snow, director of the Global HIV Vaccine Enterprise, discuss the recent AIDS Vaccine 2012 Conference that was held in Boston. "There has been so much progress in every aspect of HIV prevention research over the last three years that [researchers] had plenty to report," they write, adding, "[I]t is increasingly clear that defeating HIV will require the combined application of a number of interventions." They review the results of several studies and comments from several speakers and conclude, "[S]cientific partnership across borders and oceans has long been a hallmark of HIV vaccine development. That, after all, is what brought the field to where it is now: on the verge of a transformation" (Barton, 10/1).
This article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.